Ionolyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate)

Ionolyte is used for fluid and electrolyte replacement in clinical situations that involve electrolyte depletion or volume loss.

• Electrolyte replacement: restores magnesium, potassium, sodium and acetate levels in patients with hypomagnesemia, hypokalemia, hyponatremia or metabolic acidosis.
• Fluid resuscitation: expands plasma volume in patients with hypovolemia due to dehydration, hemorrhage or surgery.
• Correction of electrolyte deficiencies: normalises specific electrolyte concentrations in acute or chronic hyponatremia, hypokalemia and hypomagnesemia.

• Ionolyte delivers magnesium, potassium, sodium and acetate ions directly into the bloodstream via intravenous infusion. The supplied magnesium and potassium ions replenish intracellular and extracellular stores, supporting neuromuscular function and cardiac electrophysiology. Sodium ions expand extracellular fluid volume, enhancing plasma osmolarity and blood pressure. Acetate is metabolized to bicarbonate, helping correct metabolic acidosis. Together, these ions restore electrolyte homeostasis and improve circulatory volume.

Ionolyte may be associated with infusion‑related reactions and electrolyte disturbances.

Common Side Effects

• Infusion site irritation: mild pain or redness at the catheter site.
• Transient hypotension: temporary drop in blood pressure during administration.
• Nausea: occasional feeling of queasiness.
• Headache: mild to moderate headache during or after infusion.
• Mild hyperkalemia: slight increase in serum potassium levels.
• Mild hypermagnesemia: slight increase in serum magnesium levels.

Serious or Rare Side Effects

• Severe hyperkalemia: marked elevation of potassium that can cause cardiac arrhythmia.
• Severe hypermagnesemia: high magnesium levels leading to respiratory depression or cardiac arrest.
• Anaphylactic reaction: rare severe allergic response requiring immediate medical intervention.
• Cardiac arrhythmia: abnormal heart rhythm due to electrolyte imbalance.
• Pulmonary edema: fluid accumulation in the lungs from rapid volume expansion.
• Metabolic acidosis: rare worsening of acid‑base status despite acetate administration.

When using Ionolyte, clinicians should consider patient‑specific factors and monitor for potential complications.

• Renal impairment: monitor electrolyte levels and adjust infusion rate.
• Cardiac disease: watch for arrhythmias caused by rapid electrolyte shifts.
• Pregnancy: use only if the potential benefit justifies the potential risk to the fetus.
• Concomitant electrolyte supplements: avoid duplication that could lead to excess serum concentrations.
• Store at ambient temperature: keep in the original container, protect from light and moisture.

Ionolyte can interact with other medications that affect electrolyte balance or infusion compatibility.

Major Interactions (Avoid)

• Calcium gluconate: may precipitate with magnesium, causing line blockage.
• Potassium‑sparing diuretics: increase risk of severe hyperkalemia.
• ACE inhibitors: can exacerbate hyperkalemia when combined.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may increase electrolyte loss, requiring dose adjustment.
• Beta‑blockers: may mask symptoms of electrolyte imbalance.
• IV fluids containing potassium: cumulative potassium load may necessitate monitoring.